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Thoracoscopy in Pleural Malignant Mesothelioma
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(Received 6 June 1996; revised 9 July 1996; infinalform 7August 1996)
On the basis of our personal experience in 70 cases (66 pleural effusions) observed
during the period January 1984- January 1996 we are here illustrating and discussing
the diagnostic role of thoracoscopy in malignant pleural mesothelioma.
A histological diagnosis was achieved in 94.2% of cases. The endoscopic appearance
was clearly neoplastic (masses, nodules) in 53 patients (75.7%) and simply inflamma-
tory in 17 pachypleuritis in 13 (18.6%) and of diffuse hyperemia in 3 (5.7%). In all
cases fluid cytology (diagnostic yield: 18.5%) and needle biopsy (diagnostic yield
17.1%) were performed.
The extension of pleural involvement (endoscopic staging according to Boutin) was
also determined. In 16 patients (22.8%) a parietal and diaphragmatic involvement
(stage la) was found. In 40 patients (57.2%) an associated visceral invasion (stage Ib).
In 14 cases (20%) a diffuse parietal, visceral and mediastinal extension (stage II).
The exam has always been well tolerated with few immediate complications: subcu-
taneous emphysema (4 cases) and some negligeable parietal bleeding (2 cases).
Keywords: pleural mesothelioma, diagnosis, thoracoscopy, pleural effusion
INTRODUCTION
There are still considerable difficulties in the
diagnosis of pleural mesothelioma, both because
of its aspecific clinical manifestations and be-
cause of the limited sensitivity of traditional
X-rays and of computed axial tomography.
Fluid cytology and needle biopsy have only
partially improved chances of identifying the
pathology (Whitaker and Shikin 1984; Leong et
al. 1992).
Thoracoscopy however, which has become a
much more widely used method in recent years,
in expert hands allows a correct diagnosis to be
made in nearly all cases, thereby equalling the
accuracy previously produced only by thoracot-
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omy (Boutin and Rey 1993). The procedure not
only allows adequate and abundant tissue sam-
pling for immunohistochemical staining which is
essential for differential diagnosis from adeno-
carcinoma (Leong and Vernon-Roberts 1994)
but also allows staging of the disease which is a
useful prognostic factor and an important ele-
ment in deciding therapy (Boutin et al. 1993).
This report aims at illustrating and discussing
the diagnostic role of thoracoscopy in mesothe-
lioma on the basis of our experience in 70 cases.
MATERIALSAND METHODS
70 cases of pleural malignant mesothelioma were
diagnosed at thoracoscopy first in the Pneumol-
ogy Division of the Spedali Civili in Brescia
(1984-1986) and then in the Pneumology Divi-
sion of the Ospedale di Valle Camonica (1987-
1996) (Table I), between January 1984 and Jan-
uary 1996. During this period for diagnostic
purposes in pleural disease ofunknown etiologyb
we carried out a total of 470 thoracoscopies so
the disease was diagnosed in 14.9% of the diag-
nostic examinations.
49 of the patients were male (70%) and 21
were female (30%) with a M/F ratio of 2.3/1.
Indications for thoracoscopy were pleural effu-
sion in 66 patients (94.2%), while the existence of
pleural thickening without exudation was the
only anomaly found in 4 (5.8%). The right side
was affected in 36 cases (51.4%), the left in 34
(48.6%), there were no bilateral cases. The aver-
age age was 61 years (min 41 yrs, max 84 yrs).
Anamnesis for occupational exposure to asbes-
TABLE Thoracoscopy in Pleural Mesothelioma
Personal experience
(1984-1996)
Patients (n) 70
Patients aged < 60 a. (n) 28
Average age (yrs) 61.4
Pleural effusion (n) 66
(M49; F21)
(40%)
(94.2%)
tos was definitely positive in only 17 (24.2%)
cases and negative or not clear in the remaining
53.
All patients underwent pleural fluid cytology
and closed pleural biopsy by Cope needle. The
day before thoracoscopy, any pleural fluid
present was aspirated and pneumothorax was
then induced using a Morelli device; intrapleural
pressures were determined which together with
radioscopic control checked the degree of paren-
chymal collapse, according to our usual tech-
nique (Tassi and Marchetti 1993). The average
amount of air insuttlated was 100-300 ml, which
gave a space of at least 5 cm between the lung
and the chest wall.
The actual thoracoscopy was always per-
formed under local anesthesia (10-15 ml ido-
caine 2%), inserting Boutin’s rigid thoracoscope
(Wolf Co., Knittlingen, Germany) connected to a
video camera for monitor viewing into the 5th
-6th intercostal space on the midaxillary line
using a single port. A second point of entry was
necessary only in 4 cases in order to reach areas
otherwise inaccessible. The entire pleural area
was always explored and multiple biopsy samples
(5-10) were taken both in any suspicious areas
and in sites apparently without macroscopically
evident lesions. In 3 patients with apparently
normal visceral pleura and coexistent fibrohya-
line parietal plaques, pleural biopsies were inte-
grated with samples from the lung parenchyma
using a coagulating forceps.
At the end of the endoscopy, when indicated,
poudrage was performed using an asbestos-free
talc to induce symphysis (2.5-5 g): 29 patients
were so treated.
In all cases a chest tube for drainage (24-
28 Fr) was inserted and left in place for an aver-
age of 3 days (min. a few hours, max 7 days).
Since 1992, 39 patients have undergone local
preventive radiotherapy 10-15 days after the
examination, with a total dose of 21 Gy over 3
days to a depth of 3 cm over an area between 50
and 100 cm2 centered over each point of entry
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RESULTS
Exploration of the pleural cavity was straight
forward in 59 patients (84-2%) since in these
cases there were no adhesions, whereas in 11
patients (15.8%) complete exploration was made
difficult; by the presence of adhesions which,
even after lysis with forceps, sometimes partly
hindered the procedure. However even in these
cases the biopsies taken usually allowed a correct
diagnosis to be made.
Most of the lesions observed (Table II) were
clearly neoplastic (Fig. 1): isolated nodules or
multiple lesions (vegetations; masses; thicken-
ings). Diffuse pachypleuritis was found less
frequently (Fig. 2) and simple inflammation
(Fig. 3) only rarely. Moreover the presence of
fibrohyaline plaques with the characteristics of
asbestotic plaques was noted in 13 patients
(18.6%).
Biopsy allowed the diagnosis of pleural malig-
nant mesothelioma in 66 patients (94.2%) and
also provided its histological classification
(Table III) with a marked prevalence of epithelial
type. In 2 cases in which biopsies were insuffi-
cient due to extensive adhesions which pre-
vented a complete exploration of the cavity diag-
nosis was made after thoracotomy. In another 2
cases diagnosis was reached with a second thora-
coscopy performed some months later due to the
reappearance of the effusion. In all 3 patients
submitted to forceps parenchymal biopsy we ob-
tained a diagnosis of pulmonary asbestosis with-
out complications using a coagulating forceps
which insured the aerostasis of the lung therefore
avoiding air leak.
TABLE II Pleural Mesothelioma (n 70)
Endoscopic pictures
Inflammation
Nodules
Pachypleuritis
Multiple lesions
%
4(5.7)
17 (24.3)
13(18.6)
36 (51.4)
FIGURE
FIGURE 2
Thoracoscopy also allowed Boutin classifica-
tion of the disease according to the degree of
pleural involvement: in 16 cases (21.8%) only the
parietal and diaphragmatic pleura were involved
(stage Ia), 40 (57.2%) presented visceral invasion
(stage Ib), and 14 (20%) massive invasion of all
the pleural surfaces (stage II).
Talc poudrage made in 29 cases achieved a
permanent pleurodesis with no recurrence of
effusion in 24 patients (83%).
Thoracoscopy was always well tolerated and
there were no major complications immediately
after the procedure. Minor complications in-
cluded subcutaneous emphysema in 4 patients
(5.7%) and minor parietal bleeding in 2 (2.8%).
Later complications included 3 (4.3%) cases of150 G.F. TASSI et al.
TABLE IV Pleural Mesothelioma (n 70)
Diagnostic means
%
Fluid cytology 13/70 (18.5)
Pleural needle biopsy 12/70 (17.1
Thoracoscopic biopsy 66/70 (94.2)
FIGURE 3
TABLE III Pleural Mesothelioma (n 70)
Histological type
%
Epithelial 55 (78.6)
Sarcomatous 5 (7.1)
Mixed cell 7 (10)
Other 3 (4.3)
neoplastic invasion of the thoracic scar, all of
them in the first 31 patients not treated by local
radiotherapy. This no longer occurred in the
remaing 39 who had a radiation therapy.
DISCUSSION
In recent years thoracoscopy has been enjoying a
second youth and has become an invaluable
method in the diagnosis of pleural effusions in
general and mesothelioma in particular. In ex-
pert hands the examination is diagnostic in the
vast majority of cases, reducing the need for
exploratory thoracotomy which has higher mor-
bidity and mortality (Weatherford et al. 1995).
Ifwe compare data regarding the sensitivity of
the methods used before thoracoscopy the clear
advantage of the latter is striking. Our experience
(Table IV), similar in results to other large case
studies, shows that mesothelioma can be diag-
nosed by thoracoscopy in 94% of cases: much
higher than the 17/18% diagnostic yield ofneedle
biopsy and fluid cytology.
Even thoracoscopy does not however reach
100% sensitivity. The small percentage of false
negatives present in all the studies is usually due
to the presence of adhesions which cannot be
divided endoscopically and which therefore pre-
vent a complete exploration or the pleural cavity.
It should be noted that this is usually the case
when thoracoscopy is delayed too long and often
eventually performed several months after the
appearance of an effusion. It can therefore be
supposed, and our experience confirms this, that
a prompt use of the method in the investigation
of pleurisies which have not been diagnosed with
other means can further increase sensitivity.
Clearly neoplastic lesions (vegetations; nod-
ules; multiple lesions) were present in 75.7% of
our cases showing that a generic diagnosis of
malignancy at endoscopy is possible in most
patients. However there can be more deceptive
pictures of simple inflammation or of generic
pachypleuritis (1/4 of our patients) and these
cases emphasize the need for multiple biopsies
from a wide range of sites.
Asbestotic type fibrohyaline plaques (an irreg-
ular surface with a ’candle wax drop’ appear-
ance), which we observed in 13 (18.6%) ofour 70
patients are also useful for diagnosis: these
plaques found together with clearly neoplastic
lesions (nodules or masses) (Fig. 4) clearly point
to a diagnosis of mesothelioma. In fact during
our experience in neoplastic pleurisy in 400 tho-
racoscopies we have never found these plaques
associated with other tumors. Another useful
point to remember is that when fibrohyalineTHORACOSCOPY IN PLEURAL MALIGNANT MESOTHELIOMA DIAGNOSIS 151
FIGURE 4
technique of pleurodesis (Walker-Renard et al.
1994). Its complete efficacy in 83% of the cases
avoided the need for painful thoracentesis which
also exposes patients to the risk of neoplastic
seeding.
Tolerance to the examination was very good,
and there were no fatalities which further proves
that thoracoscopy, if correctly performed, pre-
sents no particular risks or complications.
We can therefore conclude that the role of
thoracoscopy in mesothelioma nowadays is un-
deniably fundamental, both for diagnostic and
therapeutic purposes, and it should be systemat-
ically utilized in all suspicious cases.
plaques are found but occupational exposure has
not been proved, lung biopsy with coagulating
forceps can be performed during the same thora-
coscopy session and under local anesthesia,
thereby demonstrating an eventual asbestosis.
We, like other authors (Rusch 1995), used
thoracoscopic staging for therapeutic approach.
In fact only fairly recently has it been discovered
that mesothelioma which has invaded the vis-
ceral pleura after primitive involvement of the
parietal and diaphragmatic pleura has a much
worse prognosis and that in its early stages the
disease may respond to an efficacious treatment
(Astoul et al. 1993, Boutin et al. 1994).
Therefore, latterly, 3 stage Ia patients were
treated surgically with pleurectomy and 6 with
intracavitary drugs (immunotherapy with
gamma-interferon and chemotherapy with cis-
platin) after the positioning of a device for intra-
pleural infusion. The number of patients treated
is too small to be able to draw conclusions but we
consider the clinical results ofthis approach to be
encouraging. Obviously this treatment was possi-
ble only after thoracoscopy, once again under-
lining its usefulness in the modern clinical/
therapeutical management of pleural tumor.
In the case of more extensive involvement
(stages Ib and II) in patients with massive and
recurrent effusions we performed talc poudrage
which is still generally considered as the best
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